Business Description
OMRON Corp
ISIN : DE0008647488
Share Class Description:
FRA:OMR: Shs German Cert.Total Employee Number:
26,614Description
Omron Corporation, founded in 1933 and headquartered in Kyoto, Japan, is a leading global manufacturer specializing in automation, sensing, and control technologies. The company operates through diverse business segments, including industrial automation, healthcare, social systems, device & module solutions, and data solutions. Its offerings range from factory automation equipment, electronic components, and social infrastructure systems to medical devices and healthcare data analytics. With operations across Japan, Asia, the Americas, Europe, and other regions, Omron plays a pivotal role in advancing industrial productivity, healthcare innovation, and social infrastructure, guided by its mission of "improving lives and contributing to a better society."
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.69 | |||||
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.29 | |||||
Debt-to-EBITDA | 2.71 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.76 | |||||
Beneish M-Score | -2.59 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4 | |||||
3-Year EBITDA Growth Rate | -10.5 | |||||
3-Year EPS without NRI Growth Rate | -21 | |||||
3-Year FCF Growth Rate | -2.2 | |||||
3-Year Book Growth Rate | 4.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 32.17 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.2 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.83 | |||||
Quick Ratio | 1.41 | |||||
Cash Ratio | 0.45 | |||||
Days Inventory | 153.33 | |||||
Days Sales Outstanding | 73.1 | |||||
Days Payable | 79.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 2 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -0.67 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 45.74 | |||||
Operating Margin % | 7.19 | |||||
Net Margin % | 3.71 | |||||
EBITDA Margin % | 11.59 | |||||
FCF Margin % | 1.02 | |||||
OCF Margin % | 7.9 | |||||
ROE % | 3.59 | |||||
ROA % | 2.01 | |||||
ROIC % | 3.52 | |||||
3-Year ROIIC % | -6.99 | |||||
ROC (Joel Greenblatt) % | 14.19 | |||||
ROCE % | 4.82 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 41.82 | |||||
Forward PE Ratio | 25.53 | |||||
PE Ratio without NRI | 32.97 | |||||
Shiller PE Ratio | 23.71 | |||||
Price-to-Owner-Earnings | 61.29 | |||||
PS Ratio | 1.55 | |||||
PB Ratio | 1.42 | |||||
Price-to-Tangible-Book | 3.59 | |||||
Price-to-Free-Cash-Flow | 152.51 | |||||
Price-to-Operating-Cash-Flow | 19.56 | |||||
EV-to-EBIT | 25.91 | |||||
EV-to-EBITDA | 16.08 | |||||
EV-to-Revenue | 1.86 | |||||
EV-to-FCF | 183.02 | |||||
Price-to-GF-Value | 1.2 | |||||
Price-to-Projected-FCF | 1.35 | |||||
Price-to-Median-PS-Value | 1.03 | |||||
Price-to-Graham-Number | 2.29 | |||||
Earnings Yield (Greenblatt) % | 3.86 | |||||
FCF Yield % | 0.66 | |||||
Forward Rate of Return (Yacktman) % | -4.17 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OMRON Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 4,356.275 | ||
| EPS (TTM) (€) | 0.812 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -34.93 | ||
| 3-Year Sortino Ratio | -3.45 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | 31.94 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 31.94 - 31.94 | ||
| Shares Outstanding (Mil) | 196.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OMRON Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OMRON Corp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-11-06 | In 123 days | ||
| Second quarter earnings results for 2027 | 2026-11-06 | In 123 days | ||
| First quarter earnings conference call for 2027 | 2026-08-06 | In 31 days | ||
| First quarter earnings results for 2027 | 2026-08-06 | In 31 days | ||
| General meeting for 2026 | 2026-06-23 10:00 | 31.94 (+0.00%) | ||
| Annual report for 2026 | 2026-06-22 | 31.94 (+0.00%) | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-13 | 31.94 (+0.00%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-13 | 31.94 (+0.00%) | ||
| Third quarter earnings conference call for 2026 | 2026-02-05 | 31.94 (+0.00%) | ||
| Third quarter earnings results for 2026 | 2026-02-05 | 31.94 (+0.00%) |
Show
Entries
OMRON Corp Frequently Asked Questions
What is OMRON Corp(FRA:OMR)'s stock price today?
The current price of FRA:OMR is €31.94. The 52 week high of FRA:OMR is €31.94 and 52 week low is €31.94.
When is next earnings date of OMRON Corp(FRA:OMR)?
The next earnings date of OMRON Corp(FRA:OMR) is 2026-08-06 Est..
Does OMRON Corp(FRA:OMR) pay dividends? If so, how much?
OMRON Corp(FRA:OMR) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Advancing Early Detection: OMRON Healthcare Supports May Measurement Month 2026 | 2026-04-27 | ||
| OMRON Healthcare and UCSF launch AFib trial | 2026-04-02 | ||
| OMRON Healthcare releases new Women's Heart Health Factbook | 2026-03-07 |
Articles on OMRON Corp
No articles.